insights_auto
Why is CGTX down 7.01%?
Dive Deeperchevron_right
CGTX:NASDAQ
Cognition Therapeutics Inc
$0.64
arrow_downward
-7.01%(-0.048) 1D
$0.62
arrow_downward
-1.64% (-0.010)bedtimeAfter hours
Closed: Nov 5, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CGTX...
Open
$0.72
High
$0.72
Low
$0.62
Mkt. cap
60.72M
Avg. vol.
543.47K
Volume
696.17K
52-wk high
$1.82
52-wk low
$0.55
EPS
-$0.20
Beta
1.84
Shares outstanding
95.09M
No. of employees
14
Open
$0.72
High
$0.72
Low
$0.62
Mkt. cap
60.72M
Avg. vol.
543.47K
Volume
696.17K
52-wk high
$1.82
52-wk low
$0.55
EPS
-$0.20
Beta
1.84
Shares outstanding
95.09M
No. of employees
14
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
Cognition Therapeutics, Inc. Q3 2026 Earnings Call Summary
Yahoo Finance
·
7 hours ago
Cognition Therapeutics Q3 Earnings Call Highlights
Investing.com Canada
·
15 hours ago
Form 8K Cognition Therapeutics Inc For: 5 November By Investing.com
TradingView
·
15 hours ago
CGTX: DLB trial planning advanced as cash runway extends into Q4 2027
About Cognition Therapeutics Inc
CEO-
Employees14
FoundedJan 1, 2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecogrx.com